Jefferies Financial Group’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$371K Hold
285,110
﹤0.01% 1322
2026
Q1
$368K Hold
285,110
﹤0.01% 1328
2025
Q4
$630K Hold
285,110
﹤0.01% 1261
2025
Q3
$462K Hold
285,110
﹤0.01% 1103
2025
Q2
$738K Hold
285,110
0.01% 812
2025
Q1
$1.92M Hold
285,110
0.02% 594
2024
Q4
$1.94M Sell
285,110
-1,206
-0.4% -$7.94K 0.01% 675
2024
Q3
$2.37M Buy
286,316
+1,206
+0.4% +$8.73K 0.02% 542
2024
Q2
$1.81M Buy
285,110
+50,000
+21% +$384K 0.02% 566
2024
Q1
$2.18M Sell
235,110
-50,000
-18% -$586K 0.02% 564
2023
Q4
$3.64M Hold
285,110
0.02% 493
2023
Q3
$2.95M Hold
285,110
0.03% 491
2023
Q2
$3.74M Sell
285,110
-10
-0% -$122 0.03% 436
2023
Q1
$3.19M Buy
285,120
+10
+0% +$99 0.03% 510
2022
Q4
$2.4M Buy
+285,110
New +$2.71M 0.02% 595

Other funds holding LUNG

Jefferies Financial Group's LUNG Position: Q2 2026 in Review

Jefferies Financial Group held its Pulmonx (LUNG) position steady in Q2 2026 at 285,110 shares worth $371K. The position accounts for ﹤0.01% of the portfolio, ranked #1322.

Jefferies Financial Group first reported a position in LUNG in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.74M in Q2 2023. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Jefferies Financial Group held 285,110 shares of Pulmonx worth $371K as of Q2 2026.
  • Jefferies Financial Group left its Pulmonx share count unchanged in Q2 2026.
  • Pulmonx made up ﹤0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #1322 holding.
  • Jefferies Financial Group first reported a position in Pulmonx in Q4 2022 and has held it in 15 quarters since.
  • Jefferies Financial Group's Pulmonx position peaked at $3.74M in Q2 2023.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.